{"url_path":"/sec/cochw/8-k/2026-05-18/item-5-02","section_key":"item-5-02","section_title":"Item 5.02 ** **Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.**","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-05-18","source_url":"https://www.sec.gov/Archives/edgar/data/1840877/0001213900-26-058429-index.html","accession_number":"0001213900-26-058429","cik":"0001840877","ticker":"COCH","issuer_name":"Envoy Medical, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1840877/0001213900-26-058429-index.html","primary_entity_key":"0001840877","primary_entity_name":"Envoy Medical, Inc."},"word_count":250,"has_tables":true,"body_markdown":"**Item 5.02** **Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.**\n\n \n\nOn May 12, 2026,\nEnvoy Medical, Inc. (the “Company”) held its 2026 Annual Meeting of Stockholders (the “Annual Meeting”).\nAt the Annual Meeting, the Company’s stockholders (the “Stockholders”) approved (the “Stockholder Approval”):\n(i) an amendment to the Company’s 2023 Equity Incentive Plan (the “Equity Incentive Plan”) to authorize\nan additional 6,000,000 shares of the Company’s Class A Common Stock, par value $0.0001 per share (“Common Stock”),\nfor issuance under the Equity Incentive Plan (the “Equity Plan Amendment”) and (ii) an amendment to the Company’s\n2023 Employee Stock Purchase Plan (the “Employee Stock Purchase Plan”) to authorize an additional 1,200,000 shares\nof Common Stock for issuance under the Employee Stock Purchase Plan (the “Purchase Plan Amendment”).\n\n \n\nThe Company’s Board\nof Directors approved each of the Equity Plan Amendment and the Purchase Plan Amendment subject to Stockholder approval at the Annual\nMeeting. Each of the Equity Plan Amendment and the Purchase Plan Amendment became effective at the time of Stockholder Approval.\n\n \n\nCopies of the Equity\nPlan Amendment and Purchase Plan Amendment are attached to this Current Report on Form 8-K as Exhibits 10.1 and 10.2, respectively, and\nare incorporated herein by reference. The material terms of the Equity Incentive Plan and Employee Stock Purchase Plan, as amended, are\nset forth in the Company’s definitive proxy statement relating to the Annual Meeting filed with the Securities and Exchange Commission\non April 2, 2026."}